BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 22 filers reported holding BIOPHARMX CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,000 | -63.6% | 43,216 | -55.9% | 0.00% | -100.0% |
| Q4 2018 | $11,000 | -47.6% | 98,004 | -12.7% | 0.00% | 0.0% |
| Q3 2018 | $21,000 | -83.6% | 112,279 | -80.6% | 0.00% | -83.3% |
| Q2 2018 | $128,000 | +29.3% | 580,070 | +35.9% | 0.01% | +20.0% |
| Q1 2018 | $99,000 | +130.2% | 426,837 | +184.4% | 0.01% | +150.0% |
| Q3 2017 | $43,000 | – | 150,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 16,128,515 | $3,561,000 | 0.46% |
| Virtu Financial LLC | 580,070 | $128,000 | 0.01% |
| FRG Family Wealth Advisors LLC | 30,000 | $7,000 | 0.00% |
| FRANKLIN RESOURCES INC | 9,749,615 | $2,153,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 671,686 | $148,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 16,779 | $4,000 | 0.00% |
| OPPENHEIMER & CO INC | 35,000 | $8,000 | 0.00% |
| CREDIT SUISSE AG/ | 50,003 | $11,000 | 0.00% |
| MORGAN STANLEY | 100 | $0 | 0.00% |
| Invesco Ltd. | 51,964 | $11,000 | 0.00% |